We support private equity, venture, and strategic investors evaluating and scaling healthcare investments where clinical, regulatory, or AI related risk materially affects value.
Our work focuses on identifying where execution risk truly resides, separating signal from narrative, and supporting informed underwriting and post acquisition decision making.
Representative Areas of Focus
- Clinical, regulatory, and AI diligence
- Development risk assessment
- Portfolio company advisory
- Post acquisition execution strategy